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Male infertility is directly or indirectly responsible for 60% of cases involving reproductive-age couples with
fertility-related issues. Nevertheless, the evaluation of male infertility is often underestimated or postponed. A
coordinated evaluation of the infertile male using standardized procedures improves both diagnostic precision and
the results of subsequent management in terms of effectiveness, risk and costs. Recent advances in assisted
reproductive techniques (ART) have made it possible to identify and overcome previously untreatable causes of
male infertility. To properly utilize the available techniques and improve clinical results, it is of the utmost
importance that patients are adequately diagnosed and evaluated. Ideally, this initial assessment should also be
affordable and accessible. We describe the main aspects of male infertility evaluation in a practical manner to
provide information on the judicious use of available diagnostic tools and to better determine the etiology of the
most adequate treatment for the existing condition.
KEYWORDS: Infertility; Diagnosis; Male; Semen Analysis; Review.
Esteves SC, Miyaoka R, Agarwal A. 2011;66(4): PAGES An update on the clinical assessment of the infertile male. Clinics. 2011;66(4):691-700.
Received for publication on February 17, 2011; First review completed on February 18, 2011; Accepted for publication on February 18, 2011
E-mail: s.esteves@androfert.com.br
Tel.: 55 19 3295-8877
INTRODUCTION
Recently, important advances have been achieved in the
field of male infertility in both diagnostics and treatment.
Genetic tests have made it possible to correctly classify cases
of non-obstructive azoospermia (NOA) previously believed
to be idiopathic. Microsurgery has increased the success
rates of reproductive tract reconstruction and sperm
retrieval either from the testicle or the epididymis. With
the advent of gamete micromanipulation, previously infer-
tile men with severe oligozoospermia or azoospermia were
given the chance to father children of their own.
Infertility is a common scenario at the urologist’s office,
and approximately 8% of men of reproductive age seek
medical attention for infertility problems. Of these, up to
10% present with a reversible cause affecting their fertility
potential; varicocele represents 35% of these cases.1 As such,
the male partner must be systematically evaluated in every
investigation of an infertile couple.
Because 80% of couples are able to achieve pregnancy
within the first year of attempting, a couple should only be
diagnosed as infertile after one year of regular sexual
activity without using a contraceptive method. Investigation
is initiated earlier when risk factors are present, including
advanced maternal (.35 years) or paternal age (.45 years),
a history of urogenital surgery, cancer, cryptorchidism,
varicocele, orchitis, use of gonadotoxins or genital infec-
tions, among others.
The urologist is responsible for diagnosing, counseling
and treating the underlying cause whenever possible. When
there is no specific treatment he/she is still responsible for
referring the patient to a specialized assisted reproductive
techniques (ART) center or, if the urologist is a member of
an ART center’s multi-professional team, for extracting the
male gamete from the testicle or epididymis.
How big is the problem?
For healthy young couples, the probability of achieving
pregnancy per reproductive cycle is approximately 20 to
25%. The cumulative probabilities of conception are 60%
within the first 6 months, 84% within the first year and 92%
within the second year of fertility-focused sexual activity.2
Infertility is a common clinical problem affecting 13 to
15% of couples worldwide.3 The prevalence varies through-
out different countries, being higher in the underdeveloped
nations where limited resources for diagnosis and treatment
exist.4 In the United Kingdom, infertility is believed to affect
one in six couples.5 According to Kamel, it should be
regarded as a public health problem, as it affects not only
the health care system but also the social environment.2
What are the mechanisms involved in sperm
production and ejaculation?
The testicles are responsible for producing the gametes
(spermatozoa) within the seminiferous tubules and sexual
hormones (testosterone and androstenedione) in the inter-
stitial cells. According to recent data, the duration of
spermatogenesis in humans, from the initiation of sperm
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production to ejaculation, is no longer than 60 days.6 The
seminal parameters of an individual actually represent the
result of influential biological, physical and occupational
factors that have been present within the two months prior
to semen collection. The hormonal control of sperm
production involves the hypothalamus (gonadotropin
releasing hormone [GnRH]), the anterior pituitary gland
(gonadotropins – follicle-stimulating hormone [FSH] and
luteinizing hormone [LH]), and the testicles (testosterone
and inhibin). The storage and maturation of spermatozoa
occur in the epididymis. The maturation process is,
however, only fully completed within the female reproduc-
tive tract. The duration of spermatozoa transit throughout
the epididymis is approximately 12 days. Both seminal
vesicles and the vas deferens have a common embryologic
origin. As such, when congenital bilateral absence of vas
deferens (CBAVD) is diagnosed, it is often associated with
seminal vesicle hypoplasia/agenesia. This aspect is impor-
tant in terms of the differential diagnosis of azoospermia. In
most CBAVD cases, the semen volume is reduced and the
semen does not contain fructose. Under normal conditions,
spermatozoa are stored in the epididymides. At the time of
ejaculation, ductal and epididymal muscle contractions
under sympathetic stimulation conduct the spermatozoa
towards the prostatic urethra where they join fluids
excreted by both the prostate and seminal vesicles to form
semen. Periurethral muscle contraction is responsible for
expelling the semen out of the urethra. Interference in any of
these steps may lead to male infertility, and the pathophy-
siological mechanism involved is dependent on which
organ or regulatory system is afflicted.
What are the causes of male infertility/subfertility?
Any process that affects sperm production and quality is
potentially harmful to male fertility. The major causes for
male infertility include varicocele, genital tract obstruction,
testicular failure, cryptorchidism, idiopathic, gonadotoxin
exposure, genetic conditions, infections, hormonal dysfunc-
tion, immunological conditions, ejaculatory/sexual dys-
function, cancer and systemic diseases.
From a group of 2,383 male infertility patients who attended
our tertiary center for male reproduction, 48.4% of the
individuals had conditions that were potentially correctable
by surgical or medical treatment. The other half consisted
of candidates for assisted reproduction, particularly ART
involving in vitro fertilization (IVF) coupled with intracyto-
plasmic sperm injection (ICSI) (Table 1).
What are the signs?
The typical clinical situation is the presentation of an
infertile couple within reproductive age who are sexually
active and do not use any contraceptive methods but are
unable to achieve pregnancy. In general, the female partner
is evaluated by a gynecologist who orders a semen analysis
for the male. If the semen analysis results are abnormal, then
male infertility is suspected.
What are the possible confounding causes?
In approximately 1% of cases, male infertility may be the
clinical presentation of a more serious or potentially fatal
disorder such as testicular or brain cancer, medullary spinal
cancer, endocrinopathies, genitourinary malformation, sys-
temic disease and genetic syndromes.7,8 Testicular cancer is
about 50 times more common in infertile men.9 Therefore, it is
important for the clinician to keep in mind that infertility may
be the initial manifestation of a more severe medical
condition.
How to proceed with the diagnostic evaluation of
the male partner?
Initial workup. Medical history. A detailed medical
history should be obtained for any factor that may impact
fertility potential. Information regarding the following areas
should be collected: a) prior fertility, previous diseases
during childhood and puberty such as viral orchitis and
cryptorchidism; c) surgeries performed, especially those
involving the pelvic and inguinal regions and genitalia; d)
genital traumas; e) infections such as orchiepididymitis and
urethritis; f) physical and sexual development; g) social and
sexual habits; h) exposure to gonadotoxic agents such as
radiotherapy or chemotherapy, recent fevers or heat
exposures, and i) current or recent medications and j) a
family history of birth defects, mental retardation,
reproductive failure or cystic fibrosis. In Table 2 we
present a summary of the factors that should be
considered when assessing the infertile male.
Physical Examination. Appropriate sexual development
must be assessed. In the presence of diminished Body hair
distribution, gynecomastia or eunuchoid proportions,
androgen deficiency should be suspected.
Genital examination can reveal the presence of a
hypospadiac urethral meatus, pathologic curvature of the
phallus or an active sexually transmitted disease.
Normal adult testicles should have a 4 cm length and a
2.5 cm width, resulting in a volume of approximately 20 mL.
Testicular volume can be estimated using a pachymeter or
an orchidometer (Figure 1A). Testicles should present with a
firm consistency. Approximately 85% of the testicular
parenchyma is involved in spermatogenesis, but there is
no lower limit for testicular volume to exclude the presence
of spermatozoa. As such, testicle size cannot be relied on as
a clinical marker to preclude a trial of sperm retrieval.10
Both primary and secondary testicular failure may lead to
bilateral testicular hypotrophy. When serum testosterone is
low, the volume of seminal fluid is often small. An
endocrine workup helps to distinguish both conditions.
High FSH levels accompanied by normal or low testoster-
one levels imply primary testicular failure. These patients
Table 1 - Distribution of Diagnostic Categories in a Group
of Infertile Men Who Attended a Male Infertility Clinic.
Category N %
Varicocele 629 26.4
Infectious 72 3.0
Hormonal 54 2.3
Ejaculatory dysfunction 28 1.2
Systemic diseases 11 0.4
Idiopathic 289 12.1
Immunologic 54 2.3
Obstruction 359 15.1
Cancer 11 0.5
Cryptorchidism 342 14.3
Genetic 189 7.9
Testicular failure 345 14.5
TOTAL 2,383 100.0
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should be offered a genetic evaluation for chromosomal
abnormalities and Y chromosome microdeletions. The
combination of low serum FSH levels and low testoster-
one levels suggests hypogonadotropic hypogonadism,
especially if bilateral atrophic testicles are present. In this
scenario, serum LH is also often low. These men should
undergo cranial imaging and ‘‘serum prolactin assessment’’
to exclude pituitary gland diseases.11
The epididymides should also be evaluated according to
their size and consistency. A healthy epididymis should be
firm, but an obstructed epididymis is augmented and
ingurgitated (soft). The partial or complete absence regres-
sion of an epididymis may represent CBAVD. The vasa are
easily palpable inside the posterior aspect of the spermatic
cord as a distinct, firm, round, ‘‘spaghetti-like’’ structure. A
unilateral or bilateral congenital absence of the vas results in
oligozoospermia or azoospermia, respectively. Narrowing
areas of the vasa deferentia may represent a sequelae
resulting from an infection or trauma.
The absence of the vasa deferentia or vasal agenesis is a
clinical diagnosis and does not depend on complementary
imaging. However, 25% of men with unilateral vasal
agenesis and approximately 10% of men with CBAVD also
have unilateral renal agenesis and should undergo an
abdominal ultrasound to identify this condition.12
Physical examination is the method of choice for the
diagnosis of varicocele and should be performed with the
patient standing in a warm room13. This method has a
sensitivity and specificity of approximately 70%.14
Varicoceles diagnosed by this method are termed ‘‘clinical’’
and may be graded according to their size. In varicocele
patients, a venous dilation exists and may be enhanced
during the Valsalva maneuver. Large visible veins seen
through the scrotal skin are indicative of grade III
varicoceles (Figure 2). Moderate (grade II) and small-sized
varicoceles (grade I) have dilated veins that are palpable
without and with the aid of the Valsalva maneuver,
respectively.15 No standardized diagnostic method has been
defined for the identification of varicoceles.16
Inguinal and genital areas may reveal scars from previous
surgical interventions such as hydrocele correction and
inguinal hernia repairs which may account for damage to
the testicular blood supply and to the vas deferens.
Semen analysis. Although semen analysis does not test
sperm function, it is the cornerstone of the initial laboratory
Table 2 - Clinical Male Infertility History Outline.
1) Infertility History
Age of partners, length of time the couple has been attempting to
conceive
Contraceptive methods/duration
Previous pregnancy (current partner/other partner)
Previous treatments
Treatments/evaluations of female partner
2) Sexual History
Potency, libido, lubricant use
Ejaculation, timed intercourse, frequency of masturbation
3) Childhood and Development
Cryptorchidism, hernia, testicular trauma
Testicular torsion, infection (e.g., mumps)
Sexual development, puberty onset
4) Personal History
Systemic diseases (diabetes, cirrhosis, hypertension)
Sexually transmitted diseases, tuberculosis, viral infections
5) Previous Surgeries
Orchidopexy, herniorrhaphy, orchiectomy (testicular cancer, torsion)
Retroperitoneal and pelvic surgery
Other inguinal, scrotal and perineal surgery
Bariatric surgery, bladder neck surgery, transurethral resection of the
prostate
6) Gonadotoxin Exposure
Pesticides, alcohol, cocaine, marijuana abuse
Medication (chemotherapy agents, cimetidine, sulfasalazine,
nitrofurantoin, allopurinol, colchicine, thiazide, b– and a–blockers,
calcium blockers, finasteride)
Organic solvents, heavy metals
Anabolic steroids, tobacco use
High temperatures, electromagnetic energy
Radiation (therapeutic, nuclear power plant workers), etc.
7) Family History
Cystic fibrosis, endocrine diseases
Infertility in the family
8) Current Health Status
Respiratory infection, anosmia
Galactorrhea, visual disturbances
Obesity
Figure 1 - Tools commonly used during the physical examination of subfertile males. A) Photograph of the Prader orchidometer. It is
used to measure the volume of the testicles and consists of a chain of 12 numbered beads of increasing size from 1 to 25 mL. The beads
are compared with the testicles of the patient and the volume is read off the bead that most closely matches the size of the testicle. Pre-
pubertal sizes are 1 to 3 mL, pubertal sizes are 4 to 12 mL and adult sizes are 15 to 25 mL. B) Schematic illustration depicting the use of
the 9 Mhz pencil-probe Doppler stethoscope for varicocele examination. The patient is examined in the upright position and the
conducting gel is applied to the upper aspect of the scrotum. A venous ‘‘rush’’ may be heard during the Valsalva maneuver, indicating
blood reflux.
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evaluation and provides information on the status of the
germ epithelium, epididymides and the accessory sexual
glands. The analysis may also provide data from which a
prognosis of fertility or the diagnosis of infertility can be
extrapolated.17
It is recommended that the semen is collected in a
specialized andrology laboratory and analyzed by well-
trained technicians under rigorous quality control stan-
dards.18 Nonetheless, the prognostic value of semen
components, such as sperm number, motility and morphol-
ogy, as surrogate markers of male fertility is influenced by
many other factors related to sexual activity and the
function of accessory sex glands, among others. Routine
semen analysis has its own limitations and does not account
for putative sperm dysfunctions such as immature chroma-
tin or fragmented DNA. Results from at least two, but
preferably three, separate seminal analyses must be
obtained before a definitive conclusion can be drawn, as
wide biological variability may exist within the very same
individual. The interval between the analyses is arbitrary
and is generally recommended to be 1-2 weeks. Ejaculatory
abstinence should occur for a minimum of two days to a
maximum of seven days, with two to three days being
ideal.19 Longer periods of abstinence may lead to higher
ejaculatory volumes and increased spermatozoa quantity,
but motility is usually negatively affected. The specimen is
collected by masturbation, and care must be taken to avoid
spillage outside the container which can be misinterpreted
as hypospermia. Collection should preferentially be done in
a private room and no lubricant should be used. If collected
at home, the specimen should be brought to the lab within
30 minutes and should be kept close to the body in an effort
to maintain physiological temperature during transporta-
tion. The specimen must be allowed to liquefy for 30 to
60 minutes before being analyzed. Routine seminal analysis
should include a) the physical characteristics of semen,
including liquefaction, viscosity, pH, color and odor; b)
specimen volume; c) sperm count; d) sperm motility and
progression; e) sperm morphology; f) leukocyte quantifica-
tion and g) fructose detection in cases where no spermato-
zoa are found, especially if the total volume of the sample is
less than 1 mL. The World Health Organization (WHO)
criteria used to define normality have recently been
updated,19 as shown in Table 3. Approximately 2,000 men
from eight countries whose partners had a time-to-preg-
nancy of # 12 months were chosen to provide reference
distributions for semen parameters. One-sided lower
reference limits (the fifth centile) were generated and have
been proposed to be used as the lower cutoff limits for
normality (Table 3). Apart from the total sperm number per
ejaculate, the lower limits of these distributions are lower
than the previously presented normal or reference values20-22
but are in agreement with recent observations made from
studying populations of fertile and infertile couples.23-25
A morphometric description of spermatozoa using the
strict criteria described by Kruger26 was incorporated in the
new WHO guidelines. Low values of 3–5% normal forms
have been found by others to be optimal cut-off values
between fertile and infertile men whose spermatozoa were
used for in vitro fertilization,27 intrauterine insemination28
and in spontaneous pregnancies.29 Interpretation of the
reference ranges requires an understanding that they
provide a description of the semen characteristics of recent
Figure 2 - Photograph of a large left grade III varicocele that can
be seen through the scrotal skin.
Table 3 - Reference Values for Semen Parameters, as Published in Consecutive WHO Manuals.
Semen parameters WHO, 1992 WHO, 1999 WHO, 20101
Volume $ 2 mL $ 2 mL 1.5 mL
Sperm concentration/mL $ 206 106/mL $ 206106/mL 156106/mL
Total sperm concentration $ 406 106 $ 406106 396106
Total motility (% motile) $ 50% $ 50% 40%
Progressive Motility2 $ 25% (grade a) $ 25% (grade a) 32% (a + b)
Vitality (% alive) $ 75% $ 75% 58%
Morphology $ 30%3 14%4 4%5
Leukocyte count , 1.06 106/mL , 1.06 106/mL , 1.06 106/mL
WHO = World Health Organization.
1Lower reference limit obtained from the lower fifth centile value.
2Grade a = rapid progressive motility (. 25 mm/s); grade b = slow/sluggish progressive motility (5–25 mm/s); Normal = 50% motility (grades a + b) or 25%
rapid progressive motility (grade a) within 60 min of ejaculation.
3Arbitrary value.
4No actual value given, but multicenter studies refer to . 14% (strict criteria) for in vitro fertilization (IVF).
5Normal shaped spermatozoa according to Tygerberg (Kruger) strict criteria.
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fathers. The reference limits should not be over-interpreted
to distinguish fertile men from infertile men, although they
represent the semen characteristics associated with couples
who have achieved pregnancy within 12 months of
unprotected sexual intercourse. No single aspect of semen
analysis was able to solely distinguish between fertile and
infertile men, although morphology was suggested to be the
most important. The coexistence of multiple altered seminal
parameters increases the risk for infertility,23 but semen
characteristics need to be interpreted in conjunction with the
patient’s clinical information. The reference limits provided
by the WHO manual are from semen samples that initiated
natural conceptions and help in identifying men who may
need infertility treatment, but they should not be used to
determine the nature of that treatment.
Abnormal white blood cell (leukocyte) counts are a
frequent cause of male infertility. The incidence of leuko-
cytospermia (.1 million leukocytes/mL of semen) in
infertile men varies between 3 and 23% and has been
correlated with clinical and subclinical genital infections,
elevated levels of reactive oxygen species, elevated anti-
sperm antibody levels and deficient sperm function.30
Neutrophils are predominant among the inflammatory cells
and may be both identified and quantified using different
methods and coloring techniques such as as peroxidase,
morphology, granulocyte elastase and immunohistology.
The Endtz test is a simple low-cost option to detect the
presence of peroxidase within neutrophils,31 and it has been
widely used to determine the presence of granulocytes in
the semen.
Regarding sperm counts, azoospermic patients should
have their diagnosis confirmed by verifying the lack of any
spermatozoa in centrifuged seminal fluid on two separate
occasions using a high-powered microscope. Azoospermia
with low ejaculate volume (,1.0 mL) not related to
hypogonadism or CBAVD can be caused by ejaculatory
dysfunction, although the most common cause is ejaculatory
duct obstruction (EDO). When suspected, EDO can be
confirmed by assessing the seminal pH and fructose levels,
as normal semen is alkaline and contains fructose.
Complementary workup. Endocrine evaluation. Endo-
crine evaluation is suggested when the following scenarios
are present32: a) a sperm concentration , 10 million/mL; b)
erectile dysfunction; c) hypospermia (volume ,1 mL) or d)
signs and symptoms of endocrinopathies or hypogonadism.
The minimal evaluation includes the assessment of serum
follicle-stimulating hormone (FSH) and testosterone levels,
which reflect germ cell epithelium and Leydig cell status,
respectively. If the testosterone level is low, a second
collection is recommended along with free testosterone, LH
and prolactin measurements. Isolated FSH elevation is
usually indicative of severe germ cell epithelium damage.
Highly elevated FSH and LH levels, when associated with
low-normal or below normal testosterone levels, suggest
diffuse testicular failure and may have either a congenital
(e.g., Klinefelter syndrome) or acquired cause. Concomitant
low levels of FSH and LH may implicate hypogonadotropic
hypogonadism. This condition may be congenital or
secondary to a prolactin-producing pituitary tumor.
Gonadotropin values within the normal range suggest an
extraductal obstruction in azoospermic subjects. However,
azoospermic patients with testicular failure and testis
histology exhibiting sperm maturation arrest and 10% of
those diagnosed with Sertoli-cell-only syndrome may
present with non-elevated FSH levels.32
Serum estradiol levels should be determined in patients
presenting with gynecomastia. Infertile patients with a
testosterone to estradiol ratio less than 10 can harbor
significant but reversible seminal alterations.33 Vaucher
et al.34 suggested that hyperestrogenism secondary to a
higher conversion rate of testosterone into estradiol in
Klinefelter syndrome (KS) patients inhibits testosterone
production via a negative feedback pathway and may
indicate the overexpression of aromatase CYP19 in the
testis. As such, there would be a scientific rationale for the
use of aromatase inhibitors in KS patients.33
In azoospermic men with a normal ejaculate volume, FSH
serum level greater than two times the upper limit of the
normal range is reliably diagnostic of dysfunctional sper-
matogenesis and, when found, a diagnostic testicular biopsy
is usually unnecessary, although no consensus exists in this
matter.11
Serum prolactin levels should be determined in infertile
men with a complaint of concomitant sexual dysfunction or
when there is clinical or laboratory evidence of pituitary
disease; however, hyperprolactinemia is rarely a cause of
infertility in healthy men35. Although hormonal alterations
may be present in approximately 10% of men who undergo
assessment, clinically significant changes affect less than 3%
(Table 1).
Genetic evaluation. Male infertility can be associated
with various genetic factors, including chromosomal
aberrations, genetic alterations and Y chromosome
microdeletions. Chromosomal aberrations are assessed
through G-band karyotyping. Genetic mutations and Y
chromosome microdeletions may be also assessed by the
analysis of the peripheral blood as such, DNA is amplified
by the polymerase chain reaction (PCR) biomolecular
technique. Table 4 summarizes the indications and
recommended tests for genetic evaluations.
Chromosomal abnormalities may be present in approxi-
mately 6% of infertile men, and the prevalence is inversely
correlated with sperm count. Azoospermic men can be
affected in up to 16% of cases.36 Sex chromosomal
aneuploidy (Klinefelter syndrome; 47,XXY) is the most
Table 4 - Indications for Genetic Testing in Male
Infertility.
Indications Recommended tests
Men with infertility of unknown
etiology and sperm concentrations
, 10 million/mL who are candidates
for ART
Y chromosome microdeletion
and G-band karyotyping
Non-obstructive azoospermia in a male
considering testicular sperm retrieval
for ART
Y chromosome microdeletion
and G-band karyotyping
Azoospermic or oligozoospermic men
with the absence of at least one vas
deferens at physical examination
CFTR gene mutation analysis
Azoospermic men with signs of normal
spermatogenesis (e.g., obstructive
azoospermia of unknown origin)
CFTR gene mutation analysis
History of recurrent miscarriage or
personal/familiar history of genetic
syndromes
G-band karyotyping
ART = assisted reproductive techniques.
G-band karyotyping = Giemsa band karyotyping.
CFTR = cystic fibrosis transmembrane conductance regulator.
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frequent chromosomal disorder present in infertile men and
is generally associated with hypotrophic or atrophic
testicles, elevated serum FSH levels and azoospermia,
although spermatogenesis can be differently affected in
patients with a mosaic karyotype (46,XY/47,XXY). The
mutation of the cystic fibrosis gene (CFTR gene), which is
located on the long arm of chromosome 7, is also a relatively
common genetic disorder. Depending on the mutation
length, cystic fibrosis can manifest as its full clinical
presentation (an autosomic recessive potentially fatal dis-
ease) or as a mild form that affects approximately 1.3% of
infertile men in which there is a congenital bilateral absence
of the vasa deferentia. Cystic fibrosis transmembrane
conductance regulator (CFTR) gene mutations compromise
the development of Wolffian duct-derived structures (effer-
ent ducts, epididymis and vasa deferentia) and may also be
implicated in seminal vesicle hypoplasia or agenesis and
unilateral renal agenesis. Approximately 80% of men
presenting with CBAVD have a CFTR mutation, and as
the genetic testing is not 100% sensitive, these subjects
should be assumed to harbor the genetic anomaly. Testing
should also be offered to the female partner, as she may also
be a carrier (an approximately 4% risk), before using his
sperm for assisted conception. After genetic testing, genetic
counseling should be offered.11 Recent data suggest that
azoospermic men with an idiopathic obstruction and those
presenting with the triad composed by chronic sinusitis,
bronchiectasis and obstructive azoospermia (Young
Syndrome) have an elevated risk for the CFTR mutation.36
The long and short arms of the Y chromosome are related to
spermatogenesis and testicle development, respectively.
The Y chromosome region related to infertility is called
the azoospermia factor (AZF) locus. The locus can harbor
complete or partial microscopic deletions that are isolated or
in combination with one another, and in non-overlapping
subregions called AZFa, AZFb, AZFc and AZFd. These
subregions contain multiple genes that control different
steps of spermatogenesis.
The most common Y chromosome deletion in infertile men
is the one affecting the DAZ gene (deleted in azoospermia)
located in the AZFc region. Severe oligozoospermia or
azoospermia can be seen in these cases. Y chromosome
microdeletions are found in 15% of men with azoospermia
and in 6% of men presenting with severe oligozoospermia
(,1 million/mL).36 For sperm counts between 1 and
5 million/mL, the detection rate drops down to 1.7%.37
Detecting Y chromosomal microdeletions provides predic-
tive information regarding the success of sperm retrieval for
intracytoplasmic sperm injection (ICSI). AZFa and AZFb
microdeletions present as azoospermia are associated with
germ cell aplasia and maturation arrest, respectively. In such
cases, attempts at sperm retrieval are not recommended
because there is virtually no chance of finding testicular
sperm.38,39 In AZFc microdeletion cases, sperm can be
retrieved in approximately 71% of patients.37 Clinical
pregnancy rates obtained via assisted conception are essen-
tially the same for idiopathic azoospermic patients who can
also have their sperm retrieved.
Testing also yields information for genetic counseling, as
sons of men with Y chromosomal microdeletions will
inevitably inherit the abnormality and may also be
infertile.40,41
Structural abnormalities in the autosomes, such as
inversions and translocations, are also higher in infertile
men. Gross karyotypic abnormalities are related to an
elevated risk of miscarriages and having children with both
chromosomal and congenital defects. As such, men with
non-obstructive azoospermia or severe oligozoospermia
should be karyotyped before their sperm are used for
ICSI.11
Figure 3 - Magnetic resonance imaging showing enlarged seminal vesicles with lithiasis.
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Transrectal, scrotal and renal ultrasonography. Trans-
rectal ultrasonography (TRUS) is recommended in certain
situations, including low semen volumes (,1.5 mL), ab-
normal digital rectal examination (DRE) and ejaculatory
disorders (anejaculation, hematospermia, painful ejaculation).
TRUS allows for the evaluation of the distal extraductal
system (seminal vesicles and ejaculatory ducts). EDO may
be congenital or acquired and may present as either
complete or partial. This disorder can be identified with
TRUS by the presence of seminal vesicle enlargement and
by the visualization of cysts at the ejaculatory ducts.42 When
CBAVD is diagnosed, TRUS can reveal abnormalities such
as hypoplasia or agenesis at the seminal vesicles. A recent
study has suggested that a combination of scrotal ultra-
sound and TRUS may not only distinguish between
obstructive and non-obstructive azoospermia (NOA) but
may also determine the etiologic classification of obstructive
azoospermia (OA). The sensitivity, specificity and accuracy
of combined assessment in discriminating between OA and
NOA were 95.3%, 97.2% and 96.0%, respectively.43 Seminal
vesicle aspiration and seminal vesiculography may be
performed under TRUS guidance and may help to establish
the diagnosis of EDO.44
Scrotal ultrasonography should be performed to evaluate
palpable nodules or testicular masses. Its use for subclinical
varicocele diagnosis is controversial, as several studies have
demonstrated that there is no clinical benefit from surgical
treatment in this situation.45 When there is a doubtful
physical examination, such as in obese patients, or there is
difficulty in assessing the contralateral side of a clinically
detectable varicocele, then ultrasonography is useful;
correction of a subclinical varicocele concomitant to a
clinical contralateral varicocele might be justified in this
scenario. The commonly accepted color Doppler ultrasono-
graphy criterion for the diagnosis of a varicocele (maximum
vein diameter of 3 mm or greater) has a sensitivity of about
50% and a specificity of 90% compared with 70% of physical
examination.14, 46 A pencil-probe Doppler (9 MHz) stetho-
scope is an inexpensive tool that may aid in the diagnosis of
the varicocele. The patient is examined in the upright
position, and a venous ‘‘rush’’ caused by blood reflux is
heard during the performance of the Valsalva maneuver
(Figure 1B). However, Hirsh et al. demonstrated that more
than 50% of men without clinical varicoceles exhibited a
Valsalva maneuver Doppler-positive reflux47, and therefore
this data should be interpreted in conjunction with other
patient’s findings.
Unfortunately, none of these adjunctive diagnostic meth-
ods can precisely differentiate between clinical and sub-
clinical varicoceles, and the significance of a positive test
result using any of these adjuvant techniques in infertile
men remains uncertain.
Urinary tract ultrasonography is suggested for the
evaluation of renal status in patients diagnosed with
CBAVD. Renal agenesis may be present in 10% of patients
with CBAVD and 25% of those with a unilateral absence of
the vas deferens.48
Magnetic Resonance Imaging. The use of magnetic
resonance imaging (MRI) in infertility investigations has
gained importance in recent years. Situations such as the
presence of a varicocele, EDO, seminal vesicle agenesis and
undescended testis can be seen.49
Pelvic MRI helps to clarify, in detail, the pictorial changes
initially seen with TRUS (Figure 3). Moreover, MRI has
traditionally been used to exclude cranial pathologies
manifested by hormonal disturbances.
There is evidence of the optimal usefulness of pituitary MRI
in men with hypogonadism when prolactin levels are greater
than twice the normal range or have symptoms suggesting a
worrisome intracranial abnormality (such as headache, visual
disturbances or diffuse metabolic derangements, among
others).50 In general, pituitary abnormalities can be identified
in 25% of hypogonadal men. Of these, however, empty sella
and pituitary non-functional microadenomas do not require a
specific treatment and cast doubts about the cost-effectiveness
of their diagnosis.
Nuclear magnetic resonance spectroscopy has recently
been proposed as a possible tool to identify metabolic
signatures for different histological states in infertile men.
On the basis of the ex vivo analysis of testicular biopsy
specimens, concentrations of 19 tissue metabolites were
acquired and then reassessed in men with a diagnosis of
NOA. A singular pattern could be determined for two testis
histological states: normal and Sertoli-cell-only (SCO)
Syndrome. Proliferating germ cells are linked to high
phospholipid synthesis and elevated phosphocholine levels.
A normal spermatogenesis spectroscopic pattern shows
high peaks of phosphocholine, unlike in cases of SCO.
Further research in this area may aid in the identification of
a distinct metabolic signature for the presence of sperm,
regardless of testis histopathology.51
Sperm Function Laboratory Tests. In 10 to 20% of
infertile couples who undergo basic infertility
investigations, all diagnostic workups will yield normal
results, and the couples will be etiologically classified as
having idiopathic infertility. Additional tests have been
developed to identify functional disorders and other sperm
abnormalities which are not addressed by conventional
semen analysis. Some of the additional tests are only
utilized as research tools.52 Others, such as sperm DNA
fragmentation and anti-sperm antibody testing, have
already been implemented in clinical practice.
Sperm DNA fragmentation seems to be one of the most
important causes of reduced fertility potential9. Sperm
populations with decreased DNA integrity is often asso-
ciated with advanced paternal age, inadequate dietary
intake, drug abuse, environmental pesticide exposure,
tobacco use, varicocele, medical diseases, hyperthermia,
air pollution, genital inflammation and infectious diseases.
Fragmentation can be secondary to internal factors such as
apoptosis and oxidative stress (a physiological mechanism
that is secondary to a high concentration of free radicals), or
external factors such as the presence of leukocytes. An
assessment of sperm DNA integrity is suggested in the
following situations: a) infertile men present with a normal
semen analysis as determined by conventional methods; b)
recurrent spontaneous abortion; c) to determine the most
suitable assisted reproductive technology. Abnormally
fragmented sperm DNA can be found in 5% of infertile
men with normal semen analyses and in 25% of infertile
men with abnormal parameters, but is rarely seen in fertile
men.9 The most common methods used to determine
fragmentation rates are Transferase-mediated dTUP nick-
end labeling (TUNEL), Comet, the acridine orange test and
the SCSA (Sperm Chromatin Structure Assay). The TUNEL
technique seems to be the most suitable test, as it offers the
possibility to precisely identify all existing endogenous
breaks in sperm DNA. This test combines both enzymatic
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Figure 4 - Algorithms for the workup of the infertile male. Algorithm to be considered on initial assessment (top). Algorithm for the
management of the patient presenting with azoospermia (bottom).
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and immunohistochemical techniques for the direct obser-
vation of DNA fragmentation using fluorescence micro-
scopy or flow cytometry. Elevated sperm DNA
fragmentation rates significantly diminish the chances for
natural and assisted pregnancies.53
Risk factors for anti-sperm antibody (ASA) formation
include genital infections, testicular trauma or surgical
biopsy, cryptorchidism, testicular damage secondary to
excessive heat exposure and obstruction of the extratesti-
cular ductal system (e.g., vasectomy). ASA can alter sperm
motility and sperm-oocyte interaction. The immunobead
test uses human anti-immunoglobulin antibody-coated
polyacrylamide beads that are capable of detecting IgA
and IgG, the two most clinically important immunoglobulin
subtypes associated with immunological infertility.54 This
assay precisely detects antibodies in the serum, in seminal
plasma or bound to the surface of the sperm. Rates of sperm
binding to beads above 20% are considered clinically
significant. Antibodies that are bound to sperm are the
most likely to induce functional alterations, such as
dysfunctions in motility, vitality and the capability of the
sperm to interact with eggs.
Advances in biomolecular techniques are transforming the
scientific landscape of sperm cell biology. Novel tests are
emerging from andrology research laboratories that may
soon become clinically available. The ’omics revolution, as it
is termed, refers to the study of genes (genomics), transcripts
(transcriptomics), proteins (proteomics) and the various
metabolites (metabolomics).55 With these technologies,
inventories of lipids, proteins, metabolites and RNA species
may be determined. The application of ’omics technologies to
spermatozoa, in concert with detailed assessments of their
functional competence, may provide insights into the
biochemical basis of defective semen quality.56 This informa-
tion is likely to be useful in understanding the causes of male
infertility and in the development of rational methods for its
treatment and possible prevention.
Vasography. Vasography is indicated in a few select
cases of obstructive azoospermia and when there is reason
to suspect a unilateral obstruction (e.g., in the case of a
previous surgical intervention) in severe oligozoospermic
men with a hypotrophic contralateral testis. Vasography
and seminal vesiculography are usually undertaken by
scrotal or transrectal routes. The presence of sperm upon
microscopic analysis of the fluid recovered from the vas
deferens and seminal vesicles indicates a distal obstruction
and rules out a testicular or epididymal obstruction.
Currently, vasography is only performed concomitantly
with a surgical approach to resolve an obstruction.
Testis Biopsy. Testis biopsies are suggested in select cases
of azoospermia or severe oligozoospermia to distinguish
between obstructive and non-obstructive cases. This distinc-
tion is necessary to accurately determine the histopathology
of the testis, which may reveal normal spermatogenesis,
hypospermatogenesis, germ cell maturation arrest, germ cell
aplasia (Sertoli-cell-only syndrome), tubular sclerosis or a
combination of these conditions. Biopsies can be performed
using percutaneous or open approaches. In cases in which
biopsies are obtained for diagnostic purposes only, the
authors’ technical choice is to perform the procedure either
percutaneously or using the ‘‘window’’ open technique
without testis delivery from the scrotum. Specimens should
be placed in a fixative solution such as Bouin’s, Zenker’s or
glutaraldehyde; formalin should not be used as it may
disrupt the tissue architecture. In cases of NOA, histology
results provide important prognostic information regarding
the likelihood of retrieving spermatozoa that can be used in
ART57. However, as spermatogenesis is often limited and
focal in NOA patients, the biopsy should ideally be
performed in specialized assisted reproduction centers to
allow for sperm cryopreservation and to avoid the need for
repeated procedures.
Final Considerations
Male infertility may be responsible for 40-60% of cases
where a couple is unable to conceive and should not be
underestimated. A precise and detailed medical history,
physical examination, semen analyses and complementary
tests, as appropriate, are the key to obtaining a correct
diagnosis and to determining the best treatment strategies.
Figure 4 depicts algorithms that may aid in the initial
assessment of the infertile male.
Semen parameters within the reference interval do not
guarantee fertility, nor do values outside those limits
necessarily imply male infertility or pathology. They must
be interpreted within the context of the patient’s clinical
information. The reference limits provided by the WHO
manual are derived from semen samples used to initiate
natural conceptions; they may indicate a need for infertility
treatment but not the nature of that treatment.
When no clear cause of infertility can be determined,
additional tests such as genetic testing, sperm DNA
fragmentation and anti-sperm antibody assessments should
be considered. Novel molecular sperm function tests are
emerging in the field of andrology. The application of
proteomics, transcriptomics and metabolomics to analyze
sperm should provide a more comprehensive analysis of the
biochemical basis of defective semen quality.
Genetic evaluation is recommended in cases of severe
oligozoospermia and azoospermia, as this analysis may aid
in identifying cases in which sperm retrieval is actually
possible and may also help in counseling couples about
their potential offspring.
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